Anticancer versus antigrowth activities of three analogs of the growth-inhibitory peptide: Relevance to physicochemical properties

Anticancer Research

Volumn 26, Issue 4 B, 2006, Pages 3071-3076

  Mizejewski, Gerald J ^a   Eisele, L ^a   Maccoll, R ^a  

^a WADSWORTH CENTER   (United States)

Author keywords

Alpha fetoprotein; Anticancer peptides; Breast cancer; Prostate cancer

Indexed keywords

ALANINE DERIVATIVE; ALPHA FETOPROTEIN; AMINO ACID; C PEPTIDE; CYSTEINE; DISULFIDE; GASTRIC INHIBITORY POLYPEPTIDE; GLYCINE DERIVATIVE; PEPTIDE DERIVATIVE; SERINE DERIVATIVE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASCITES; BREAST CANCER; CANCER GROWTH; CELL CULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISULFIDE BOND; DRUG ACTIVITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HYDROPHOBICITY; IN VIVO STUDY; LONG TERM CARE; NONHUMAN; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; UTERUS;

AMINO ACID SEQUENCE; ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GROWTH INHIBITORS; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MEMBRANE PROTEINS; MICE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; UTERUS;

EID: 33746761644     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Wang XW and Xu B: Stimulation of tumor-cell growth by alpha-fetoprotein. Int J Cancer 75: 596-599, 1998.
2. Li MS, Li PF, Yang FY, He SP, Du GG and Li G: The intracellular mechanism of alpha-fetoprotein promoting the proliferation of NIH 3T3 cells. Cell Res 12: 151-156, 2002.
3. Dudich E, Semenkova L, Gorbatova E, Dudich I, Khromykh L, Tatulov E, Grechko G and Sukhikh G: Growth-regulative activity of human alpha-fetoprotein for different types of tumor and normal cells. Tumour Biol 19: 30-40, 1998.
4. Mizejewski GJ, Dias JA, Hauer CR, Henrikson KP and Gierthy J: Alpha-fetoprotein derived synthetic peptides: assay of an estrogen-modifying regulatory segment. Mol Cell Endocrinol 118: 15-23, 1996.
5. Vakharia D and Mizejewski GJ: Human alpha-fetoprotein peptides bind estrogen receptor and estradiol, and suppress breast cancer. Breast Cancer Res Treat 63: 41-52, 2000.
6. Festin SM, Bennett JA, Fletcher PW, Jacobson HI, Shaye DD and Andersen TT: The recombinant third domain of human alpha-fetoprotein retains the antiestrotrophic activity found in the full-length molecule. Biochim Biophys Acta 1427: 307-314, 1999.
7. Mizejewski GJ and MacColl R: Alpha-fetoprotein growth inhibitory peptides: potential leads for cancer therapeutics. Mol Cancer Ther 2: 1243-1255, 2003.
8. Eisele LE, Mesfin FB, Bennett JA, Andersen TT, Jacobson HI, Soldwedel H, MacColl R and Mizejewski GJ: Studies on a growth-inhibitory peptide derived from alpha-fetoprotein and some analogs. J Pept Res 57: 29-38, 2001.
9. Eisele LE, Mesfin FB, Bennett JA, Andersen TT, Jacobson HI, Vakharia DD, MacColl R and Mizejewski GJ: Studies on analogs of a peptide derived from alpha-fetoprotein having antigrowth properties. J Pept Res 57: 539-546, 2001.
10. Mizejewski G, Smith G and Butterstein G: Review and proposed action of alpha-fetoprotein growth inhibiting peptides as estrogen and cytoskeletal-associated factors. Int J Cell Biol 28: 913-933, 2004.
11. Muehlemann M, Miller KD, Dauphinee M and Mizejewski GJ: Review of growth inhibitory peptide as a biotherapeutic agent for tumor growth, adhesion, and metastasis. Cancer Metastasis Rev 24: 441-467, 2005.
12. Caceres G, Dauphinee MJ, Eisele LE, MacColl R and Mizejewski GJ: Anti-prostate cancer and anti-breast cancer activities of two peptides derived from alpha-fetoprotein. Anticancer Res 22: 2817-2820, 2002.
13. MacColl R, Eisele LE, Stack RF, Hauer C, Vakharia DD, Benno A, Kelly WC and Mizejewski GJ: Interrelationships among biological activity, disulfide bonds, secondary structure, and metal ion binding for a chemically synthesized 34-amino-acid peptide derived from alpha-fetoprotein. Biochim Biophys Acta 1528: 127-134, 2001.
14. Butterstein G, MacColl R, Mizejewski GJ, Eisele LE and Meservey M: Biophysical studies and anti-growth activities of a peptide, a certain analog and a fragment peptide derived from alpha-fetoprotein. J Pept Res 61: 213-218, 2003.
15. Mizejewski GJ, Vonnegut M and Jacobson HI: Estradiol-activated alpha-fetoprotein suppresses the uterotropic response to estrogens. Proc Natl Acad Sci USA 80: 2733-2737, 1983.
16. Mizejewski GJ, Vonnegut M and Jacobson HI: Studies of the intrinsic antiuterotropic activity of murine alpha-fetoprotein. Tumour Biol 7: 19-36, 1986.
17. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S and Boyd MR: New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82: 1107-1112, 1990.
18. Parsons DF, Foley J, Marko M and Wansor K: Immediate ascites conversion of mammary tumors induced in NYLR/Nya mice by 7,12-dimethylbenz-[a] anthracene and urethane feeding and by forced breeding. Cancer Invest 4: 109-126, 1986.
19. Richardson BE, Hulka BS, Peck JL, Hughes CL, van den Berg BJ, Christianson RE and Calvin JA: Levels of maternal serum alpha-fetoprotein (AFP) in pregnant women and subsequent breast cancer risk. Am J Epidemiol 148: 719-727, 1998.
20. Melbye M, Wohlfahrt J, Lei U, Norgaard-Pedersen B, Mouridsen HT, Lambe M and Michels KB: Alpha-fetoprotein levels in maternal serum during pregnancy and maternal breast cancer incidence. J Natl Cancer Inst 92: 1001-1005, 2000.
21. Kyte J and Doolittle RF: A simple method for displaying the hydropathic character of a protein. J Mol Biol 757:105-132, 1982.